Colorado will cap the cost of EpiPens at $60 starting in January
Coloradans who use EpiPens to treat severe allergies won’t have to pay as much for their medication starting in January.
Gov. Jared Polis signed House Bill 23-1002 on Wednesday. The bill caps the out-of-pocket cost for a two-pack of epinephrine auto-injectors at $60.
Epinephrine, also known as adrenaline, stops life-threatening allergic reactions. Most people who take it use preloaded pens, so they don’t have to measure a dose during an emergency.
The cap only applies to health insurance plans regulated by the state. (You can find out if your plan falls under it by looking for CO-DOI printed on your insurance card.) Colorado residents who don’t have a state-regulated plan and aren’t covered by Medicare or Medicaid will be able to get epinephrine auto-injectors for $60, however, if they apply for a new affordability program next year.
Wednesday was the last day for the governor to sign bills from the latest legislative session. Other health-related bills he signed in recent days include:
- SB23-195: Requires insurance companies to count “copay coupons” toward customers’ deductibles
- SB23-31: Creates a training program to improve geriatric health care
- SB23-252: Requires hospitals to post their Medicare reimbursement rates
- SB23-261: Creates a board to study ways to stabilize the direct care workforce
- SB23-298: Allows small public hospitals to collaborate in ways that otherwise might be considered anti-competitive
- SB23-299: Requires colleges and universities to have a stockpile of epinephrine auto-injectors
- HB23-1003: Creates a school mental health screening program
- HB23-1130: Limits insurance companies to requiring people with serious mental illnesses to “fail” in treatment with one cheaper psychotropic before covering the drug their doctor recommended
- HB23-1226: Standardizes hospital bills sent to patients
Sign up for our weekly newsletter to get health news sent straight to your inbox.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.